NeuroBionics

We are NeuroBionics, a neurotechnology company dedicated to revolutionizing the field of bioelectronic medicine. Our mission is to advance human health by developing implantable devices that seamlessly integrate with the human body, democratizing access to life-changing neuromodulation therapies. Founded in 2023 by a team of scientists and engineers from MIT, we are pioneering a new era of neural interfaces.

Our core technology centers on hair-thin, flexible bioelectronic fibers that can be delivered endovascularly—through the body's existing network of blood vessels—eliminating the need for invasive open-brain surgeries. This minimally invasive approach allows us to reach deep neural targets safely and effectively, offering new hope for patients suffering from conditions such as Parkinson's disease, essential tremor, epilepsy, and depression. By speaking the language of cells through electrical, chemical, and mechanical signals, our devices set a new standard for precision and biocompatibility. We are passionate about building a future where advanced neurotherapies are accessible to millions, transforming the standard of care and improving quality of life for patients worldwide.